Published in Tissue Antigens on May 01, 1998
Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol (2008) 2.22
HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs. Clin Diagn Lab Immunol (2004) 0.86
HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population. Folia Microbiol (Praha) (2012) 0.80
Polymorphisms of HLA-DRB1, -DQA1 and -DQB1 in inhabitants of Astana, the capital city of Kazakhstan. PLoS One (2014) 0.75
HL-A system and juvenile rheumatoid arthritis. Tissue Antigens (1974) 1.17
Toll-like receptors. II. Distribution and pathways involved in TLR signalling. Folia Biol (Praha) (2005) 0.99
Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab (1977) 0.99
Toll-like receptors. I. Structure, function and their ligands. Folia Biol (Praha) (2005) 0.90
Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma). Tissue Antigens (1982) 0.88
Association of HLA-DPB1 alleles with type I diabetes mellitus in Slovak population. Bratisl Lek Listy (2006) 0.87
[Study of the HLA system in the Slovak population. Incidence of Antigens of the A, B, and C locus (author's transl)]. Bratisl Lek Listy (1977) 0.85
The HLA system in glomerulonephritis. Clin Immunol Immunopathol (1977) 0.85
Letter: HL-A antigens in rheumatoid arthritis. Lancet (1974) 0.85
B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases. Bratisl Lek Listy (2009) 0.81
Single nucleotide polymorphisms of cytokine genes in the healthy Slovak population. Int J Immunogenet (2007) 0.81
Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res (2006) 0.79
HL-A2 and congenital heart malformations. Tissue Antigens (1975) 0.78
HLA-A, HLA-B and HLA-C polymorphism in the Slovak population. Folia Biol (Praha) (2000) 0.77
Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol (1999) 0.77
Characterization of MICA gene polymorphism of HLA complex in the Slovak population. Ann Hum Biol (2011) 0.77
Efficacy of recombinant herpes simplex virus 1 glycoprotein D candidate vaccines in mice. Acta Microbiol Immunol Hung (2006) 0.77
Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency. Immunobiology (1989) 0.76
Toll-like receptors. III. Biological significance and impact for human medicine. Folia Biol (Praha) (2005) 0.76
No association between bronchial asthma and HLA-DRB1, -DQB1 alleles in the Slovak population. Bratisl Lek Listy (2013) 0.76
[Frequency of the HLA-DPB1 allele in the Slovak population]. Bratisl Lek Listy (1998) 0.75
TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population. J Eur Acad Dermatol Venereol (2009) 0.75
Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp (Warsz) (1995) 0.75
[Subacute (de Quervain's) thyroiditis: immunogenetic study (author's transl)]. Bratisl Lek Listy (1978) 0.75
[HLA B27 antigen in ankylosing vertebral hyperostosis (author's transl)]. Cas Lek Cesk (1979) 0.75
[Alkaptonuria and the HLA system (author's transl)]. Cas Lek Cesk (1978) 0.75
Genetic polymorphism of factor B (Bf) and C3 component of complement in type 1 (insulin-dependent) diabetes mellitus: BFQO allele observed in a diabetic child. Folia Biol (Praha) (1993) 0.75
[Nomenclature of genes and gene products of the HLA complex 1987]. Bratisl Lek Listy (1988) 0.75
[The influence of anti HL-A antibodies upon the course and final result of gravidity (author's transl)]. Cesk Gynekol (1975) 0.75
HLA class II allele frequencies in type 1A diabetes mellitus Slovak patients. Bratisl Lek Listy (2006) 0.75
[DNA typing of class I HLA alleles]. Bratisl Lek Listy (1998) 0.75
The HLA class II antigens determined by cellular techniques. A review. Folia Biol (Praha) (1986) 0.75
[Changes in the capacity of T-lymphocytes for spontaneous recovery of selected differentiation antigens in relation to age]. Cas Lek Cesk (1999) 0.75
[Comparison of the results of HLA typing using serologic and molecular genetics methods]. Bratisl Lek Listy (2000) 0.75
[Effect of trypsinization on functional recovery of blast transformation of lymphocytes in adults and the aged]. Cas Lek Cesk (2000) 0.75
[Frequency of loci of HLA-DRB1* and -DQB1* alleles in the Slovak population]. Bratisl Lek Listy (1998) 0.75
[Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases]. Vnitr Lek (1999) 0.75
[The present state of knowledge on the major histocompatibility complex in man--HLA 1984. Report on a study trip to Italy]. Bratisl Lek Listy (1986) 0.75
[The effect of certain substances on changes in the expression of class II HLA antigens]. Cas Lek Cesk (1989) 0.75
[Determination of drug allergy by lymphocyte transformation test (LTT) (author's transl)]. Bratisl Lek Listy (1978) 0.75
[Lymphocytotoxic antibodies in patients after kidney transplantation (author's transl)]. Bratisl Lek Listy (1980) 0.75
Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines. Folia Microbiol (Praha) (2008) 0.75
Screening of immunological properties of vermiculine in selected model situations. Ann N Y Acad Sci (1997) 0.75
HLA-BW35 and subacute de Quervain's thyroiditis [proceedings]. Diabete Metab (1976) 0.75
The characteristics of the HLA antigens determined by cellular techniques. Allerg Immunol (Leipz) (1986) 0.75
[Cytotoxicity mediated by NK cells]. Bratisl Lek Listy (1987) 0.75
[Cerebral infarct and the immune response]. Bratisl Lek Listy (1997) 0.75
[Study of the HLA system in the Slovak population. Antigens determined by secondary--primed lymphocytes (author's transl)]. Bratisl Lek Listy (1978) 0.75
[Myocarditis in childhood]. Cesk Pediatr (1989) 0.75
Allogeneic BMT for haematological disorders: single centre experience of University Hospital Bratislava. Bone Marrow Transplant (1998) 0.75
[Human T-lymphocyte differentiation antigens]. Bratisl Lek Listy (1988) 0.75
[Ultrasonic fetometry in multiple pregnancy]. Rev Chil Obstet Ginecol (1979) 0.75
[Study of antigens of the HL-A system in the Slovak population. I. Incidence of HL-A antigens (author's transl)]. Bratisl Lek Listy (1974) 0.75
The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes. Folia Biol (Praha) (1993) 0.75
[An interleukin-2 preparation for the production of T-lymphocyte clones]. Bratisl Lek Listy (1987) 0.75
The role of HLA class II antigens in the induction of cytotoxic T lymphocytes. Eur J Immunogenet (1995) 0.75
[Problems in the diagnosis of drug allergy]. Cesk Dermatol (1978) 0.75
[Expression of HLA antigens using the radioimmunoanalysis method]. Bratisl Lek Listy (1989) 0.75
[The development of cytotoxic T lymphocytes in HLA-D/DR identity]. Bratisl Lek Listy (1989) 0.75
[The importance of findings on complement genetics for medicine]. Cas Lek Cesk (1985) 0.75
HLA alleles and susceptibility to dermatological disorders associated with Helicobacter pylori infection: a significant association to HLA-Cw*06. Folia Biol (Praha) (2001) 0.75
[Specific cell-mediated cytotoxicity in patients with cerebral infarct]. Cesk Neurol Neurochir (1989) 0.75
[Preparation of antiserums for the determination of transplantation antigens of the HL-A system]. Bratisl Lek Listy (1974) 0.75
[Study of the HL-A system in the Slovak population. II. Incidence of HL-A haplotypes (author's transl)]. Bratisl Lek Listy (1975) 0.75
[Mixed lymphocyte culture (MLC test) in HLA identical relatives and between HLA identical unrelated subjects (author's transl)]. Bratisl Lek Listy (1977) 0.75
[Laparoscopy]. Rev Chil Obstet Ginecol (1978) 0.75
High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population. Int J Immunogenet (2013) 0.75
The immunomodulatory properties of low-molecular tri- and tetrapeptides. Folia Biol (Praha) (1996) 0.75
[Latent autoimmune (type 1) diabetes mellitus in patients originally classified as type 2. Divergence of etiologic markers]. Cas Lek Cesk (2000) 0.75
[Effect of age on the activity of lysosomal enzymes in human polymorphonuclear leukocytes (author's transl)]. Bratisl Lek Listy (1980) 0.75
[The effect of mitogenic substances on the expression of HLA antigens]. Bratisl Lek Listy (1986) 0.75
[Functional characteristics of lymphocytes and the response to encephalitogenic peptide in patients with cerebral infarct]. Cesk Neurol Neurochir (1987) 0.75
[Genetic and molecular background in autoimmune diabetes mellitus]. Epidemiol Mikrobiol Imunol (2015) 0.75
[Transplantation antigens and the recognition of foreign elements]. Cas Lek Cesk (1988) 0.75
[Recombination between HLA-B and HLA-D loci of the major histocompatibility system in man (author's transl)]. Cas Lek Cesk (1978) 0.75
[Madelung's symmetrical lipomatosis]. Rozhl Chir (1983) 0.75
[Genetic determination of the origin of cytotoxic lymphocytes]. Bratisl Lek Listy (1983) 0.75
[The origin, differentiation and tissue distribution of NK cells]. Bratisl Lek Listy (1988) 0.75
Genetic determination of phagocytic activity of polymorphonuclear leucocytes. Folia Biol (Praha) (1988) 0.75
[Identification of LD determinants by mixed lymphocyte culture test (author's transl)]. Bratisl Lek Listy (1978) 0.75
[NK cell activity and association with the HLA class I antigen complex]. Bratisl Lek Listy (1994) 0.75
[Reaction to venous allotransplant]. Rozhl Chir (1980) 0.75
[Distribution and function of NK cells in relation to age, sex and blood group]. Cas Lek Cesk (1988) 0.75
The frequency of HLA-Dw1 determinant in subacute (de Quervain's) thyroiditis. Tissue Antigens (1979) 0.75
Are results of immunosuppressive therapy influenced by immunogenetic markers? Proc Eur Dial Transplant Assoc (1980) 0.75
Frequency of HLA antigens in persons sensitive to N-isopropyl-N'-phenyl-p-phenylenediamine (IPPD). Contact Dermatitis (1993) 0.75
[Frequency of HLA-A, HLA-B and HLA-Cw antigens in the Slovak population]. Bratisl Lek Listy (2000) 0.75
HLA-G1-transfected K562 cells do not inhibit NK-cell-mediated lysis in europium release cytotoxicity assay. Bratisl Lek Listy (2003) 0.75